MCID: EPT009
MIFTS: 23

Epithelioid Cell Synovial Sarcoma

Categories: Cancer diseases

Aliases & Classifications for Epithelioid Cell Synovial Sarcoma

MalaCards integrated aliases for Epithelioid Cell Synovial Sarcoma:

Name: Epithelioid Cell Synovial Sarcoma 12 15
Synovial Sarcoma, Epithelioid Cell 12 71
Epithelioid Synovial Sarcoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5494
NCIt 50 C4278
SNOMED-CT 67 56422000
UMLS 71 C0334506

Summaries for Epithelioid Cell Synovial Sarcoma

MalaCards based summary : Epithelioid Cell Synovial Sarcoma, also known as synovial sarcoma, epithelioid cell, is related to sarcoma and spindle cell sarcoma. An important gene associated with Epithelioid Cell Synovial Sarcoma is SSX1 (SSX Family Member 1), and among its related pathways/superpathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Transcriptional misregulation in cancer. Related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Related Diseases for Epithelioid Cell Synovial Sarcoma

Diseases related to Epithelioid Cell Synovial Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 347, show less)
# Related Disease Score Top Affiliating Genes
1 sarcoma 30.0 WT1 SSX2 SSX1 SS18 EWSR1
2 spindle cell sarcoma 29.7 SSX2 SSX1 SS18 KRT7 EWSR1 CD34
3 sarcoma, synovial 28.3 WT1 SSX2 SSX1 SS18 KRT7 EWSR1
4 meninges sarcoma 10.4 SSX2 SS18
5 malignant glandular tumor of peripheral nerve sheath 10.4 SSX2 CALB2
6 extraskeletal mesenchymal chondrosarcoma 10.3 EWSR1 CD99
7 pulmonary vein leiomyosarcoma 10.3 CD99 CD34
8 ewing sarcoma of bone 10.3 EWSR1 CD99
9 rete testis adenoma 10.3 PAX8 CALB2
10 small intestine leiomyosarcoma 10.3 CD34 ANO1
11 central nervous system mesenchymal non-meningothelial tumor 10.3 EWSR1 CD99
12 parasagittal meningioma 10.3 CD34 ANO1
13 adult fibrosarcoma 10.3 SSX1 CD34
14 gastric liposarcoma 10.3 CD34 ANO1
15 deep leiomyoma 10.3 CD34 ANO1
16 meninges hemangiopericytoma 10.3 CD99 CD34
17 epidural spinal canal neoplasm 10.3 CD99 CD34
18 infected hydrocele 10.3 SPN CALB2
19 liver leiomyoma 10.3 CD34 ANO1
20 extraosseous osteosarcoma 10.3 SSX1 CD34
21 plexiform schwannoma 10.3 CD34 ANO1
22 small intestine leiomyoma 10.3 CD34 ANO1
23 sclerosing liposarcoma 10.3 PAX8 CD34
24 retroperitoneal leiomyosarcoma 10.3 CD34 ANO1
25 transitional papilloma 10.3 UPK3A KRT7
26 renal pelvis transitional cell carcinoma 10.3 UPK3A KRT7
27 thyroid sarcoma 10.3 PAX8 CD34
28 mixed endometrial stromal and smooth muscle tumor 10.3 MME CD99
29 malignant mesenchymoma 10.3 SSX2 CD34
30 vulva adenocarcinoma 10.3 UPK3A KRT7
31 vulval paget's disease 10.3 UPK3A KRT7
32 intravascular fasciitis 10.3 CD34 ANO1
33 benign fibrous mesothelioma 10.2 CD34 CALB2
34 peritoneal benign neoplasm 10.2 CD34 CALB2
35 heart sarcoma 10.2 SSX2 SSX1 CD34
36 nephrogenic adenoma 10.2 PAX8 KRT7
37 gastric squamous cell carcinoma 10.2 UPK3A KRT7
38 papillary transitional carcinoma 10.2 UPK3A KRT7
39 pleomorphic liposarcoma 10.2 SSX2 SS18 EWSR1
40 esophagus sarcoma 10.2 SSX2 CD34
41 spindle cell lipoma 10.2 CD99 CD34
42 cellular schwannoma 10.2 SSX1 SS18 CD34
43 thyroid angiosarcoma 10.2 PAX8 CD34
44 epithelioid malignant peripheral nerve sheath tumor 10.2 SSX2 SS18 CD34
45 bladder lymphoma 10.2 SPN MME
46 glandular cystitis 10.2 UPK3A KRT7
47 bladder benign neoplasm 10.2 PAX8 KRT7
48 retroperitoneal sarcoma 10.2 SSX2 CD34 ANO1
49 lung lymphoma 10.2 SPN MME
50 bartholin's gland carcinoma 10.2 PAX8 KRT7
51 adenoid basal cell carcinoma 10.2 SPN KRT7
52 bone lymphoma 10.2 SPN MME
53 renal pelvis adenocarcinoma 10.2 PAX8 KRT7
54 breast lymphoma 10.2 SPN MME
55 central nervous system fibrosarcoma 10.2 KRT7 CD34
56 breast leiomyoma 10.2 MME CD34
57 breast myofibroblastoma 10.2 MME CD34
58 liver fibroma 10.2 SSX2 CD34 CALB2
59 mucocele of appendix 10.2 MME CD34
60 gastrointestinal lymphoma 10.2 SPN MME
61 breast leiomyosarcoma 10.1 KRT7 CD34
62 fallopian tube carcinosarcoma 10.1 WT1 CALB2
63 breast hemangioma 10.1 KRT7 CD34
64 inflammatory liposarcoma 10.1 MME CD34
65 inverted transitional papilloma 10.1 KRT7 GATA3
66 colonic lymphangioma 10.1 KRT7 CD34
67 ovarian mucinous neoplasm 10.1 PAX8 KRT7
68 kidney fibrosarcoma 10.1 SSX2 SSX1 EWSR1 CD99
69 cervical polyp 10.1 MME CD34
70 spindle cell synovial sarcoma 10.1 SSX2 SSX1 SS18 CD34
71 intravenous leiomyomatosis 10.1 MME CD34
72 sarcomatoid squamous cell skin carcinoma 10.1 MME CD34
73 ovarian serous adenofibroma 10.1 KRT7 CALB2
74 vaginal endometrial stromal sarcoma 10.1 MME CD34
75 vulvar leiomyoma 10.1 MME CD34
76 sclerosing hepatic carcinoma 10.1 MME CD34
77 urethral diverticulum 10.1 UPK3A PAX8 KRT7
78 central nervous system leukemia 10.1 MME CD34
79 neurilemmoma 10.1 CD34 CALB2 ANO1
80 sarcomatosis 10.1 WT1 EWSR1
81 lipomatosis, multiple 10.1 EWSR1 CD34 ANO1
82 invasive malignant thymoma 10.1 MME CD34
83 breast sarcoma 10.1 MME CD34
84 breast malignant phyllodes tumor 10.1 MME CD34
85 ovarian serous cystadenofibroma 10.1 KRT7 CALB2
86 subareolar duct papillomatosis 10.1 MME KRT7
87 myocardium cancer 10.1 SYP CD99
88 cervical mucinous adenocarcinoma 10.1 MME KRT7
89 nipple benign neoplasm 10.1 MME KRT7
90 malignant biphasic mesothelioma 10.1 WT1 CALB2
91 gastric diffuse adenocarcinoma 10.1 KRT7 GATA3
92 female urethral cancer 10.1 MME KRT7
93 liposarcoma 10.1 EWSR1 CD34 CALB2
94 mixed epithelial stromal tumour 10.1 MME KRT7
95 hobnail hemangioma 10.1 WT1 CD34
96 vagina sarcoma 10.1 MME CD34
97 benign breast phyllodes tumor 10.1 MME CD34
98 mucinous stomach adenocarcinoma 10.1 KRT7 CALB2 ANO1
99 clear cell papillary renal cell carcinoma 10.1 MME KRT7
100 chromophil adenoma of the kidney 10.1 MME KRT7
101 cerebellopontine angle primitive neuroectodermal tumor 10.1 SYP CD99
102 synovium neoplasm 10.1 SSX2 SSX1 SS18 KRT7
103 breast metaplastic carcinoma 10.1 MME KRT7
104 ovarian gonadoblastoma 10.1 WT1 CALB2
105 orbital cellulitis 10.1 MME KRT7
106 acute orbital inflammation 10.1 MME KRT7
107 balloon cell malignant melanoma 10.1 MME KRT7
108 cerebellar angioblastoma 10.1 WT1 EWSR1
109 esophageal adenoid cystic carcinoma 10.1 SYP ANO1
110 angiokeratoma circumscriptum 10.1 WT1 CD34
111 gastric hemangioma 10.1 SYP ANO1
112 kidney hemangiopericytoma 10.0 SSX2 SS18 CD34 CALB2
113 rete testis neoplasm 10.0 PAX8 KRT7 CALB2
114 rete testis adenocarcinoma 10.0 PAX8 KRT7 CALB2
115 adenoid squamous cell carcinoma 10.0 KRT7 CD34
116 thymus basaloid carcinoma 10.0 SYP PAX8
117 epithelial predominant wilms' tumor 10.0 WT1 KRT7
118 sarcomatous intrahepatic cholangiocarcinoma 10.0 KRT7 CD34 ANO1
119 cervical adenosarcoma 10.0 MME CD34
120 squamous papillomatosis 10.0 MME KRT7
121 fallopian tube endometrioid adenocarcinoma 10.0 PAX8 MME CALB2
122 smooth muscle tumor 10.0 MME CD34 ANO1
123 bladder adenocarcinoma 10.0 UPK3A KRT7 GATA3
124 juvenile type testicular granulosa cell tumor 10.0 WT1 CD99 CALB2
125 testicular granulosa cell tumor 10.0 WT1 CD99 CALB2
126 uterine corpus sarcoma 10.0 KRT7 CD34
127 cutaneous adenocystic carcinoma 10.0 MME KRT7
128 myxofibrosarcoma 10.0 SSX2 SS18 EWSR1 CD34
129 papillary thymic adenocarcinoma 10.0 SYP CALB2
130 apocrine adenocarcinoma 10.0 KRT7 GATA3
131 kidney sarcoma 10.0 WT1 SSX2 SSX1 SS18
132 small intestinal sarcoma 10.0 WT1 EWSR1 ANO1
133 malignant spiradenoma 10.0 KRT7 CALB2
134 neuronal intestinal dysplasia, type b 10.0 SYP CD34
135 pacinian tumor 10.0 MME CD34 CALB2
136 extracranial neuroblastoma 10.0 SYP EWSR1
137 glomangiomyoma 10.0 SYP CD34
138 lung meningioma 10.0 SYP CD34
139 cervical neuroblastoma 10.0 SYP EWSR1
140 glomangiosarcoma 10.0 SYP CD34
141 bartholin's gland disease 10.0 KRT7 GATA3 CALB2
142 biphasic synovial sarcoma 10.0 SSX2 SSX1 SS18 PAX8 EWSR1
143 benign perivascular tumor 10.0 SYP CD34
144 endocervical carcinoma 10.0 PAX8 KRT7 GATA3
145 kidney rhabdoid cancer 10.0 SYP EWSR1
146 cutaneous ganglioneuroma 10.0 SYP CD34
147 angiosarcoma 10.0 KRT7 CD34 CALB2
148 subungual glomus tumor 10.0 SYP CD34
149 heart cancer 10.0 CD34 CALB2
150 skin benign neoplasm 10.0 KRT7 EWSR1 CD34
151 nephrogenic adenoma of urinary bladder 10.0 PAX8 MME KRT7
152 wolffian duct adenoma 9.9 PAX8 MME KRT7
153 intraductal breast benign neoplasm 9.9 MME KRT7
154 clear cell hidradenoma 9.9 PAX8 MME KRT7
155 ovary neuroendocrine neoplasm 9.9 SYP KRT7
156 orbital cancer 9.9 SYP CD34
157 ovarian brenner tumor 9.9 WT1 UPK3A KRT7
158 cervical adenoma malignum 9.9 PAX8 MME KRT7
159 mucinous adenofibroma 9.9 SYP KRT7
160 lung combined type small cell carcinoma 9.9 SYP MME
161 auditory system benign neoplasm 9.9 SYP KRT7
162 pancreatic mucinous cystadenoma 9.9 MME KRT7 CALB2
163 small cell carcinoma of the bladder 9.9 SYP KRT7
164 collecting duct carcinoma 9.9 PAX8 MME KRT7
165 glomangioma 9.9 SYP CD34
166 central nervous system primitive neuroectodermal neoplasm 9.9 SYP CD99
167 urethra clear cell adenocarcinoma 9.9 UPK3A PAX8 KRT7 CALB2
168 glomangiomatosis 9.9 SYP CD34
169 cribriform carcinoma 9.9 KRT7 GATA3
170 vaginal tubulovillous adenoma 9.9 SYP KRT7
171 gallbladder small cell carcinoma 9.9 SYP KRT7
172 angiomyolipoma 9.9 PAX8 MME KRT7
173 rectum neuroendocrine neoplasm 9.9 SYP KRT7
174 middle ear adenoma 9.9 SYP KRT7
175 dedifferentiated liposarcoma 9.9 SSX2 SSX1 SS18 EWSR1 CD34
176 papillary squamous carcinoma 9.9 SYP KRT7
177 hidradenoma 9.9 MME KRT7 EWSR1
178 sensory organ benign neoplasm 9.9 SYP KRT7
179 spermatic cord cancer 9.9 WT1 SSX2 SSX1 CD34
180 connective tissue cancer 9.9 SSX2 SSX1 SS18 EWSR1 CD34
181 extraosseous ewings sarcoma-primitive neuroepithelial tumor 9.9 SYP EWSR1 CD99
182 intracranial primitive neuroectodermal tumor 9.9 SYP EWSR1 CD99
183 anaplastic ependymoma 9.9 SYP EWSR1
184 appendix adenocarcinoma 9.9 SYP KRT7
185 meibomian cyst 9.9 SYP KRT7
186 extraosseous ewing sarcoma 9.9 SYP EWSR1 CD99
187 small cell osteogenic sarcoma 9.9 SYP EWSR1 CD99
188 olfactory nerve neoplasm 9.9 SYP EWSR1 CD99
189 cranial nerve malignant neoplasm 9.9 SYP EWSR1 CD99
190 askin's tumor 9.9 SYP EWSR1 CD99
191 cranial nerve neoplasm 9.9 SYP EWSR1 CD99
192 mucinous tubular and spindle renal cell carcinoma 9.9 MME KRT7 CD34
193 ovarian seromucinous carcinoma 9.9 WT1 PAX8 KRT7
194 ovarian mixed germ cell neoplasm 9.9 WT1 PAX8 MME
195 thoracic benign neoplasm 9.9 MME KRT7 CD34
196 breast benign neoplasm 9.9 MME KRT7 CD34
197 thymus clear cell carcinoma 9.9 PAX8 GATA3 EWSR1 CALB2
198 female reproductive endometrioid cancer 9.9 WT1 PAX8 KRT7
199 endobronchial leiomyoma 9.9 SYP CD34 ANO1
200 pericardium cancer 9.9 WT1 KRT7 CALB2
201 gliofibroma 9.9 SYP CD99 CD34
202 prostate stromal sarcoma 9.9 SYP CD34 ANO1
203 adenocarcinoma in situ 9.9 WT1 PAX8 KRT7
204 fibroma 9.9 KRT7 CD99 CD34 CALB2
205 bone osteosarcoma 9.9 SYP EWSR1 CD99
206 biliary tract benign neoplasm 9.9 SYP KRT7
207 small intestine benign neoplasm 9.9 SYP CD34 ANO1
208 colon leiomyoma 9.9 SYP CD34 ANO1
209 adenomatoid tumor 9.9 WT1 KRT7 CALB2
210 bartholin's gland adenocarcinoma 9.9 UPK3A PAX8 KRT7 GATA3
211 sex cord-gonadal stromal tumor 9.9 WT1 KRT7 CALB2
212 ovary adenocarcinoma 9.9 WT1 PAX8 KRT7
213 lung sarcoma 9.9 SSX2 SSX1 EWSR1 CD34 CALB2
214 vaginal adenoma 9.9 SYP KRT7
215 renal hypodysplasia/aplasia 1 9.9 WT1 UPK3A PAX8
216 middle ear carcinoma 9.9 WT1 KRT7 EWSR1
217 adenomyoma 9.9 MME KRT7
218 cellular myxoid liposarcoma 9.8 SSX2 SSX1 SS18 EWSR1 CTAG1B CTAG1A
219 myxoid liposarcoma 9.8 SSX2 SSX1 SS18 EWSR1 CTAG1B CTAG1A
220 vaginal benign neoplasm 9.8 SYP KRT7
221 nephrogenic adenofibroma 9.8 WT1 KRT7 CD34
222 prostate neuroendocrine neoplasm 9.8 SYP KRT7
223 ureteral benign neoplasm 9.8 UPK3A SYP KRT7
224 vaginal cancer 9.8 MME KRT7
225 thyroid gland follicular carcinoma 9.8 PAX8 MME KRT7
226 cerebrovascular benign neoplasm 9.8 SYP KRT7
227 colon leiomyosarcoma 9.8 WT1 PAX8 CD34 ANO1
228 cervical serous adenocarcinoma 9.8 WT1 MME GATA3
229 microinvasive cervical squamous cell carcinoma 9.8 WT1 KRT7 GATA3
230 testicular fibroma 9.8 WT1 CD99 CD34 CALB2
231 glomus tumor 9.8 SYP CD34 CALB2
232 nasal cavity adenocarcinoma 9.8 SYP KRT7 ANO1
233 keratinizing squamous cell carcinoma 9.8 SYP KRT7
234 extraosseous chondrosarcoma 9.8 SYP SSX2 SS18 EWSR1
235 rhabdomyosarcoma 2 9.8 WT1 SSX2 SSX1 SS18 EWSR1
236 cystic basal cell carcinoma 9.8 SYP KRT7
237 connective tissue benign neoplasm 9.8 MME EWSR1 CD34 CALB2
238 papillary adenoma 9.8 SYP KRT7
239 tracheal lymphoma 9.8 SYP SPN MME
240 merkel cell carcinoma 9.8 SYP KRT7 CD99
241 krukenberg carcinoma 9.8 SYP PAX8 KRT7
242 malignant ovarian surface epithelial-stromal neoplasm 9.8 WT1 PAX8 KRT7
243 chromophobe renal cell carcinoma 9.8 MME KRT7 CTAG1B
244 ovary epithelial cancer 9.8 WT1 PAX8 KRT7
245 pulmonary artery leiomyosarcoma 9.8 MME KRT7 CD34 ANO1
246 uterus perivascular epithelioid cell tumor 9.8 PAX8 MME KRT7 CALB2
247 ovarian germ cell teratoma 9.8 SYP KRT7 CALB2
248 nephrogenic adenoma of the urethra 9.8 PAX8 MME KRT7 CALB2
249 urethral benign neoplasm 9.8 PAX8 MME KRT7 CALB2
250 ovarian germ cell cancer 9.8 SYP KRT7 CALB2
251 pulmonary sclerosing hemangioma 9.8 SYP KRT7 CALB2
252 horseshoe kidney 9.8 SYP KRT7 CALB2
253 medulloepithelioma 9.8 SYP KRT7 CALB2
254 cystic teratoma 9.8 SYP KRT7 CALB2
255 granulosa cell tumor of the ovary 9.8 SYP KRT7
256 carcinosarcoma 9.7 PAX8 MME KRT7 CALB2
257 sarcomatoid carcinoma 9.7 SYP KRT7 CALB2
258 endobronchial lipoma 9.7 SYP KRT7 EWSR1
259 bladder sarcoma 9.7 UPK3A KRT7 EWSR1 CD99 CD34
260 mesenchymal cell neoplasm 9.7 SSX2 MME EWSR1 CD34 ANO1
261 mesothelioma, malignant 9.7 WT1 KRT7 CALB2
262 mediastinal cancer 9.7 SYP KRT7 CD34
263 meckel diverticulum 9.7 SYP KRT7 CD34
264 olfactory neuroblastoma 9.7 SYP EWSR1 CD99 CALB2
265 respiratory system benign neoplasm 9.7 SYP KRT7 CD34
266 cavernous hemangioma 9.7 SYP KRT7 CD34
267 pilar sheath acanthoma 9.7 MME KRT7 CD34 CALB2
268 vascular cancer 9.7 SYP KRT7 CD34
269 chordoid glioma 9.7 SYP KRT7
270 endosalpingiosis 9.7 WT1 PAX8 KRT7 CALB2
271 reproductive organ benign neoplasm 9.7 MME KRT7 CD34 CALB2
272 ureter small cell carcinoma 9.7 SYP KRT7 GATA3
273 ovarian benign neoplasm 9.7 WT1 PAX8 KRT7 CALB2
274 urinary bladder small cell neuroendocrine carcinoma 9.7 SYP KRT7 GATA3
275 peritoneum cancer 9.7 WT1 PAX8 KRT7 CALB2
276 papillary serous adenocarcinoma 9.7 WT1 PAX8 KRT7 CALB2
277 ovarian small cell carcinoma 9.7 WT1 SYP CALB2
278 ovarian serous carcinoma 9.7 WT1 PAX8 KRT7 CALB2
279 breast neuroendocrine neoplasm 9.7 SYP KRT7 GATA3
280 cauda equina neoplasm 9.7 WT1 SYP EWSR1
281 sweat gland benign neoplasm 9.7 MME KRT7 EWSR1 CD34
282 sweat gland cancer 9.7 SYP KRT7 GATA3
283 thymoma 9.7 SYP KRT7 CALB2
284 clear cell sarcoma 9.7 WT1 SYP EWSR1
285 pancreatic serous cystadenocarcinoma 9.7 SYP MME KRT7
286 bladder lateral wall cancer 9.7 SYP MME KRT7
287 bladder leiomyoma 9.7 KRT7 EWSR1 CD34 CALB2 ANO1
288 pleomorphic rhabdomyosarcoma 9.7 SYP MME KRT7
289 benign mesothelioma 9.7 WT1 KRT7 CD34 CALB2
290 tubular adenocarcinoma 9.7 SYP MME KRT7
291 well-differentiated liposarcoma 9.6 SSX2 SSX1 SS18 KRT7 EWSR1 CD34
292 teratoma 9.6 SYP KRT7 CD99 CALB2
293 clear cell renal cell carcinoma 9.6 PAX8 MME KRT7 CALB2
294 meningioma, familial 9.6 UPK3A SYP CD34 CALB2
295 breast osteosarcoma 9.6 WT1 SPN MME KRT7
296 oncocytoma 9.6 SYP MME KRT7
297 renal adenoma 9.6 WT1 PAX8 MME KRT7
298 kidney benign neoplasm 9.6 WT1 PAX8 MME KRT7
299 adenofibroma 9.6 WT1 MME KRT7 CALB2
300 jejunal neoplasm 9.6 SYP KRT7 CD34 ANO1
301 epididymal neoplasm 9.6 WT1 MME KRT7 CALB2
302 benign teratoma 9.6 SYP PAX8 KRT7 CALB2
303 thymic carcinoma 9.6 SYP PAX8 KRT7 CALB2
304 renal cell carcinoma, papillary, 1 9.6 WT1 PAX8 MME KRT7
305 papillary carcinoma 9.6 SYP PAX8 KRT7 CALB2
306 desmoplastic small round cell tumor 9.6 WT1 SYP EWSR1 CD99
307 lung leiomyosarcoma 9.6 SYP KRT7 CD34 CALB2
308 epithelioid sarcoma 9.6 SYP KRT7 CD34 CALB2
309 kidney cortex disease 9.6 WT1 SSX2 SS18 MME KRT7
310 hemangioblastoma 9.6 SYP PAX8 MME CD34
311 hemangiopericytoma, malignant 9.5 SYP SSX2 SSX1 SS18 CD99 CD34
312 benign peritoneal mesothelioma 9.5 WT1 KRT7 CD34 CALB2 ANO1
313 monophasic synovial sarcoma 9.5 SSX2 SSX1 SS18 KRT7 CD99 CD34
314 nasal cavity olfactory neuroblastoma 9.5 SYP PAX8 MME KRT7
315 bladder clear cell adenocarcinoma 9.5 WT1 UPK3A PAX8 MME KRT7
316 cystadenoma 9.5 SYP MME KRT7 CALB2
317 ovarian sex-cord stromal tumor 9.5 WT1 MME KRT7 CD99 CALB2
318 gastrointestinal stromal tumor 9.5 WT1 SYP CD34 ANO1
319 rhabdoid cancer 9.5 WT1 SYP SSX2 SS18 EWSR1
320 seminal vesicle adenocarcinoma 9.5 WT1 PAX8 KRT7 GATA3 CALB2
321 central epithelioid sarcoma 9.5 SYP MME KRT7 CD34
322 vulvar proximal-type epithelioid sarcoma 9.5 SYP MME KRT7 CD34
323 ovarian large-cell neuroendocrine carcinoma 9.5 WT1 SYP PAX8 KRT7
324 ovarian endometrioid stromal sarcoma 9.4 WT1 SYP MME CALB2
325 ovary sarcoma 9.4 WT1 SYP MME CALB2
326 sertoli-leydig cell tumor 9.4 WT1 SYP KRT7 CALB2
327 sertoli cell tumor 9.4 WT1 SYP KRT7 CALB2
328 peripheral nervous system neoplasm 9.4 SYP EWSR1 CD34
329 cystadenofibroma 9.4 WT1 PAX8 MME KRT7 CALB2
330 epididymis adenocarcinoma 9.4 WT1 PAX8 MME KRT7 CALB2
331 epididymis cancer 9.4 WT1 PAX8 MME KRT7 CALB2
332 liver leiomyosarcoma 9.4 WT1 KRT7 GATA3 CD34 CALB2
333 retroperitoneum carcinoma 9.4 WT1 SYP KRT7 CD34
334 ewing sarcoma 9.3 WT1 SYP SSX1 SS18 EWSR1 CD99
335 peritoneal serous adenocarcinoma 9.3 WT1 SYP PAX8 KRT7 CALB2
336 renal cell carcinoma, nonpapillary 9.2 WT1 PAX8 MME KRT7 CTAG1B CALB2
337 cell type benign neoplasm 9.2 SYP KRT7 CD34
338 muscle cancer 9.2 SYP SSX2 SSX1 SS18 EWSR1 CD99
339 pheochromocytoma 9.2 SYP MME KRT7 GATA3 CALB2
340 wolffian duct adenocarcinoma 9.2 WT1 PAX8 MME KRT7 GATA3 CALB2
341 mixed cell type cancer 9.1 SYP PAX8 MME KRT7 CD34 CALB2
342 skeletal muscle cancer 9.0 WT1 SYP SSX2 SSX1 SS18 EWSR1
343 chondrosarcoma, extraskeletal myxoid 9.0 WT1 SYP SSX2 SSX1 SS18 EWSR1
344 wilms tumor 1 9.0 WT1 PAX8 MME KRT7 EWSR1 CD34
345 leber plus disease 9.0 SYP SPN MME KRT7 CD99 CD34
346 rhabdomyosarcoma 8.8 WT1 SYP SSX2 SSX1 MME KRT7
347 synovium cancer 8.7 WT1 SSX2 SSX1 SS18 KRT7 EWSR1

Graphical network of the top 20 diseases related to Epithelioid Cell Synovial Sarcoma:



Diseases related to Epithelioid Cell Synovial Sarcoma

Symptoms & Phenotypes for Epithelioid Cell Synovial Sarcoma

GenomeRNAi Phenotypes related to Epithelioid Cell Synovial Sarcoma according to GeneCards Suite gene sharing:

26 (showing 22, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-126 9.74 EWSR1
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-137 9.74 EWSR1
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-140 9.74 EWSR1
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-144 9.74 PAX8
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-146 9.74 EWSR1
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-181 9.74 PAX8
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-184 9.74 PAX8
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-213 9.74 PAX8
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-216 9.74 EWSR1
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-23 9.74 SSX1
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-25 9.74 PAX8
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-3 9.74 PAX8
13 Decreased shRNA abundance (Z-score < -2) GR00366-A-34 9.74 PAX8
14 Decreased shRNA abundance (Z-score < -2) GR00366-A-41 9.74 PAX8
15 Decreased shRNA abundance (Z-score < -2) GR00366-A-43 9.74 PAX8
16 Decreased shRNA abundance (Z-score < -2) GR00366-A-52 9.74 EWSR1 SSX1
17 Decreased shRNA abundance (Z-score < -2) GR00366-A-53 9.74 EWSR1
18 Decreased shRNA abundance (Z-score < -2) GR00366-A-76 9.74 SSX2
19 Decreased shRNA abundance (Z-score < -2) GR00366-A-77 9.74 EWSR1 PAX8
20 Decreased shRNA abundance (Z-score < -2) GR00366-A-81 9.74 EWSR1 PAX8 SSX2
21 Decreased shRNA abundance (Z-score < -2) GR00366-A-84 9.74 EWSR1
22 Decreased shRNA abundance (Z-score < -2) GR00366-A-93 9.74 PAX8

Drugs & Therapeutics for Epithelioid Cell Synovial Sarcoma

Search Clinical Trials , NIH Clinical Center for Epithelioid Cell Synovial Sarcoma

Genetic Tests for Epithelioid Cell Synovial Sarcoma

Anatomical Context for Epithelioid Cell Synovial Sarcoma

Publications for Epithelioid Cell Synovial Sarcoma

Articles related to Epithelioid Cell Synovial Sarcoma:

(showing 2, show less)
# Title Authors PMID Year
1
Pathology quiz case 1. Epithelioid synovial sarcoma (synoviosarcoma). 61
17116828 2006
2
Detection of a variant SYT-SSX1 fusion in a case of predominantly epithelioid synovial sarcoma. 61
10229776 1999

Variations for Epithelioid Cell Synovial Sarcoma

Expression for Epithelioid Cell Synovial Sarcoma

Search GEO for disease gene expression data for Epithelioid Cell Synovial Sarcoma.

Pathways for Epithelioid Cell Synovial Sarcoma

Pathways related to Epithelioid Cell Synovial Sarcoma according to GeneCards Suite gene sharing:

(showing 3, show less)
# Super pathways Score Top Affiliating Genes
1 11.4 SPN MME CD34
2 11.38 WT1 SSX2 SSX1 SS18 PAX8 EWSR1
3 11 SPN MME CD34

GO Terms for Epithelioid Cell Synovial Sarcoma

Biological processes related to Epithelioid Cell Synovial Sarcoma according to GeneCards Suite gene sharing:

(showing 10, show less)
# Name GO ID Score Top Affiliating Genes
1 cell morphogenesis GO:0000902 9.63 UPK3A SS18 GATA3
2 mesonephros development GO:0001823 9.48 PAX8 GATA3
3 mesenchymal to epithelial transition GO:0060231 9.43 WT1 GATA3
4 cellular response to gonadotropin stimulus GO:0071371 9.4 WT1 PAX8
5 otic vesicle development GO:0071599 9.37 PAX8 GATA3
6 metanephric S-shaped body morphogenesis GO:0072284 9.32 WT1 PAX8
7 metanephric epithelium development GO:0072207 9.26 WT1 PAX8
8 tRNA threonylcarbamoyladenosine metabolic process GO:0070525 9.16 CTAG1B CTAG1A
9 kidney development GO:0001822 9.02 WT1 UPK3A PAX8 MME GATA3
10 positive regulation of thyroid hormone generation GO:2000611 8.96 PAX8 GATA3

Sources for Epithelioid Cell Synovial Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....